Phase I study examining PI 3 kinase inhibitor for various tumours
4 Oct 2012
Phase I study examining PI 3 kinase inhibitor for various tumours
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
iwNHL 10: Advances in the treatment of lymphoma
Molecular stratification of breast cancer: reaching the clinic
Highlights from the 2012 NCID Meeting
International Network of bio-banks and expert centres
The impact of breast cancer in Africa
Landscape of cancer care in Bangladesh
Circulating metastasis-initiating cells in breast cancer
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy
Understanding the mechanisms of breast cancer resistance
Translational and tailored, but can we afford it?